搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
clinicaltrialsarena
3 小时
First patient dosed as Marengo’s invikafusp alfa trial expands to Europe
Marengo's Phase II trial is assessing T cell activator invikafusp alfa in the treatment of advanced PD-1 resistant solid tumours.
clinicaltrialsarena
4 小时
BMS sees success in Phase III Sotyktu psoriatic arthritis trials
Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying antirheumatic drugs.
clinicaltrialsarena
7 小时
JCR Pharmaceuticals doses first patient in paediatric growth hormone trial
The Phase III trial is set to use growth outcomes as its primary endpoint in the 52-week trial of JR-142, a long-acting growth hormone.
clinicaltrialsarena
10 小时
2024: record year for AI trials
AI continued to be shown as an invaluable tool with the potential to accelerate clinical trials and improve patient care.
clinicaltrialsarena
6 天
myTomorrows adds ISRCTN to clinical trial search
Netherlands-based global health platform myTomorrows has added the ISRCTN platform to its platform’s clinical trial search functionality. The platform now includes clinical trial information from a ...
clinicaltrialsarena
3 天
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Following positive Phase IIb trial results, RH5.1/Matrix-M has the potential to be the first blood-stage malaria vaccine brought to market.
clinicaltrialsarena
3 天
Alumis reports positive outcomes from Phase I trial of TYK2 inhibitor
Alumis has revealed encouraging results from a Phase I clinical trial of tyrosine kinase 2 (TYK2), A-005, in healthy subjects.
clinicaltrialsarena
3 天
Novo Nordisk takes a hit as CagriSema underperforms in weight loss
Novo Nordisk has announced positive results from its Phase III trial of CagriSema but fell short of a previously promised 25% weight loss.
clinicaltrialsarena
3 天
Adicet Bio doses first subject in Phase I trial of renal cell carcinoma therapy
Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.
clinicaltrialsarena
5 天
HighField gains Chinese regulatory clearance to begin solid tumour therapy trial
HighField has received clearance for its IND application from the CDE of China's NMPA to commence the Phase I trial of HF50.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈